Exporting
Our Exporting Power
EXPORTING POWER
The Start was in 1989 when MUP was desirous to be well known, not only Locally but also worldwide. It was a big dream to become one of the biggest pharmaceutical companies In the Middle East, so in 1992, the export department arose to take the responsibility of accepting such a challenge.
In 2015, MUP exported its first Insulinagypt order from our “MUP.Tech” factory on the 6th of October City, recently acquired from Eli Lilly.
In 2016, the Executive Board of the Health Ministers’ Council for Gulf Cooperation council states awarded MUP the “GCC certificate” for penicillin & cephalosporins plants, which represents a great privilege for us to enormously expand our business in this region.
EXPORT
MUP Global Appearance
MUP GLOBAL
PRESENCE
MUP faces global access challenges, by helping people in 40 countries to access high-quality medications, adding value to their life’s and supporting healthcare systems in such countries.
GLOBAL
STRATEGY
MUP’s main strategy is to provide competitive diversified solutions through talented calibers across the entire organization. Also, MUP is continuously working to upgrade its manufacturing capabilities, in order to penetrate the high tech business era.
GLOBAL
EXPANSION
MUP is seeking a leadership position as a global health care provider by offering diversified treatment options that help people around the world to enjoy healthier and happier lives.
United States
info@gmail.com
United States
info@gmail.com
United States
info@gmail.com
United States
info@gmail.com
Country Covered
Registered Products Globally
CAGR% in global market
40 Countries
MUP is committed to being among the top five transnational pharmaceutical companies in the MENA region not only manufacturing but also exporting high-quality products at affordable prices in more than 40 countries.
in 2015
first Insulinagypt order from our “MUP-Tech” factory on 6th of October City, recently acquired from Eli Lilly.
in 2016
The Executive Board of the Health Ministers’ Council for Gulf Cooperation council states awarded MUP the “GCC certificate” for penicillin & cephalosporins plants, which represents a great privilege for us to enormously expand our business in this region.
GMP Certificate
The GMP certificates received from Cote d’Ivoire. (the biggest reference country in the West African region).
40 Countries
MUP is committed to being among the top five transnational pharmaceutical companies in the MENA region not only manufacturing but also exporting high-quality products at affordable prices in more than 40 countries.
in 2015
first Insulinagypt order from our “MUP-Tech” factory on 6th of October City, recently acquired from Eli Lilly.
in 2016
The Executive Board of the Health Ministers’ Council for Gulf Cooperation council states awarded MUP the “GCC certificate” for penicillin & cephalosporins plants, which represents a great privilege for us to enormously expand our business in this region.
GMP Certificate
The GMP certificates received from Cote d’Ivoire. (the biggest reference country in the West African region).